A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins
- PMID: 1475190
- PMCID: PMC334518
- DOI: 10.1093/nar/20.23.6287
A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins
Abstract
We have generated transgenic mice that express a diverse repertoire of human sequence immunoglobulins. The expression of this repertoire is directed by light and heavy chain minilocus transgenes comprised of human protein coding sequences in an unrearranged, germ-line configuration. In this paper we describe the construction of these miniloci and the composition of the CDR3 repertoire generated by the transgenic mice. The largest transgene discussed is a heavy chain minilocus that includes human mu and gamma 1 coding sequences together with their respective switch regions. It consists of a single 61 kb DNA fragment propagated in a bacterial plasmid vector. Both human heavy chain classes are expressed in animals that carry the transgene. In light chain transgenic animals the unrearranged minilocus sequences recombine to form VJ joints that use all five human J kappa segments, resulting in a diversity of human-like CDR3 regions. Similarly, in heavy chain transgenics the inserted sequences undergo VDJ joining complete with N region addition to generate a human-like VH CDR3 repertoire. All six human JH segments and at least eight of the ten transgene encoded human D segments are expressed. The transgenic animals described in this paper represent a potential source of human sequence antibodies for in vivo therapeutic applications.
Similar articles
-
Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts.Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3720-4. doi: 10.1073/pnas.90.8.3720. Proc Natl Acad Sci U S A. 1993. PMID: 8475122 Free PMC article.
-
Class switching in human immunoglobulin transgenic mice.Ann N Y Acad Sci. 1995 Sep 29;764:536-46. doi: 10.1111/j.1749-6632.1995.tb55879.x. Ann N Y Acad Sci. 1995. PMID: 7486582
-
Somatic recombination of heavy chain variable region transgenes with the endogenous immunoglobulin heavy chain locus in mice.Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10321-5. doi: 10.1073/pnas.89.21.10321. Proc Natl Acad Sci U S A. 1992. PMID: 1438216 Free PMC article.
-
Human antibodies from transgenic mice.Int Rev Immunol. 1995;13(1):65-93. doi: 10.3109/08830189509061738. Int Rev Immunol. 1995. PMID: 7494109 Review.
-
Artificial chromosome vectors and expression of complex proteins in transgenic animals.Theriogenology. 2003 Jan 1;59(1):107-13. doi: 10.1016/s0093-691x(02)01262-1. Theriogenology. 2003. PMID: 12499022 Review.
Cited by
-
Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.MAbs. 2015;7(4):693-706. doi: 10.1080/19420862.2015.1046648. MAbs. 2015. PMID: 26018625 Free PMC article.
-
Development of therapeutic antibodies for the treatment of diseases.J Biomed Sci. 2020 Jan 2;27(1):1. doi: 10.1186/s12929-019-0592-z. J Biomed Sci. 2020. PMID: 31894001 Free PMC article. Review.
-
Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery.Nat Biotechnol. 2014 Apr;32(4):356-63. doi: 10.1038/nbt.2825. Epub 2014 Mar 16. Nat Biotechnol. 2014. PMID: 24633243
-
Monoclonal antibodies: From magic bullet to precision weapon.Mol Biomed. 2024 Oct 11;5(1):47. doi: 10.1186/s43556-024-00210-1. Mol Biomed. 2024. PMID: 39390211 Free PMC article. Review.
-
Research and development of next generation of antibody-based therapeutics.Acta Pharmacol Sin. 2010 Sep;31(9):1198-207. doi: 10.1038/aps.2010.120. Epub 2010 Aug 9. Acta Pharmacol Sin. 2010. PMID: 20694021 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials